Stay updated with breaking news from Post Effective Amendment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TORONTO, Ontario and CAMBRIDGE, Massachusetts - - ProMIS Neurosciences Inc. , a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded... | May 16, 2023
15.05.2023 - Received FDA clearance for investigational new drug (IND) application for lead therapeutic candidate, PMN310, in Alzheimer’s diseasePresented preclinical data supporting target identification and candidate differentiation across pipeline of antibody ...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ____________________________ FORM 8-K ... | May 9, 2023
Files Post-Effective Amendment No. 2 to Form S-1 Registration Statement Associated with Previously Announced Warrants and Debt Conversion Agreements ... | June 18, 2023